Australian and New Zealand Intensive Care Research Centre

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Blender Biomarkers: A BLENDER Sub-study to Evaluate the Effect of Oxygen Dose on Oxidative Stress and Organ Injury

Active, not recruiting

Conditions: Critical Illness
Cardiac Failure

First Posted Date: 2022-09-16

Last Posted Date: 2023-10-26

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 30

Registration Number: NCT05542966

Locations: 🇦🇺
Alfred Hospital, Melbourne, Victoria, Australia

Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis

Not yet recruiting

Conditions: Septic Shock
Fluid Resuscitation

Interventions: Other: Vasopressors
Other: Fluids

First Posted Date: 2022-07-12

Last Posted Date: 2024-01-09

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 7838

Registration Number: NCT05453565

Fibrinogen Early In Severe Trauma StudY II

Phase 3

Recruiting

Conditions: Trauma
Haemorrhagic Shock
Coagulopathy

Interventions: Drug: Fibrinogen Concentrate
Other: Cryoprecipitate

First Posted Date: 2022-07-08

Last Posted Date: 2023-03-02

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 850

Registration Number: NCT05449834

Locations: 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺
Gold Coast University Hospital, Gold Coast, Queensland, Australia

The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))

Conditions: Critically Ill
Long Term Outcome
Mechanical Ventilation

Interventions: Behavioral: Early activity and Mobilisation Intervention

First Posted Date: 2022-03-28

Last Posted Date: 2022-03-28

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 250

Registration Number: NCT05298982

Locations: 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
John Hunter Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal North Shore Hospital, Sydney, New South Wales, Australia

and more 13 locations

Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation

Not Applicable

Active, not recruiting

Conditions: Extracorporeal Membrane Oxygenation Complication

Interventions: Other: Early Rehabilitation

First Posted Date: 2021-08-12

Last Posted Date: 2024-12-10

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 100

Registration Number: NCT05003609

Locations: 🇦🇺
Alfred Health, Melbourne, Victoria, Australia
🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia

and more 4 locations

INTENT-Muscle (A Sub-study of INTENT)

Completed

Conditions: Critically Ill

Interventions: Dietary Supplement: Supplemental parenteral nutrition

First Posted Date: 2021-05-21

Last Posted Date: 2024-05-24

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 21

Registration Number: NCT04896515

Locations: 🇦🇺
Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺
Frankston Hospital, Frankston, Victoria, Australia
🇦🇺
Blacktown Hospital, Blacktown, New South Wales, Australia

and more 3 locations

The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO

Not Applicable

Completed

Conditions: Mechanical Ventilation Complication
Severe Acute Respiratory Infection
Covid19

Interventions: Other: VV-ECMO

First Posted Date: 2021-01-14

Last Posted Date: 2023-10-04

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 6

Registration Number: NCT04708457

Locations: 🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia
🇩🇪
Charite Universitatmedizin, Berlin, Germany

Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

Phase 2

Recruiting

Conditions: Critical Illness
Osteoporosis

Interventions: Drug: Denosumab 60 MG/ML
Drug: Zoledronic Acid 5Mg/Bag 100Ml Inj
Drug: Sodium Chloride 0.9% or 5% Dextrose Intravenous
Drug: Sodium Chloride 0.9% Injection

First Posted Date: 2020-10-29

Last Posted Date: 2024-11-07

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 450

Registration Number: NCT04608630

Locations: 🇦🇺
St Vincent's Health Sydney, Sydney, New South Wales, Australia
🇦🇺
Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺
Blacktown Hospital, Sydney, New South Wales, Australia

and more 21 locations

ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients

Phase 3

Recruiting

Conditions: Traumatic Injury
Traumatic Brain Injury
Blunt Injury
Wounds and Injuries
Major Trauma
Penetrating Injury
Trauma
Multiple Trauma

Interventions: Drug: Epoetin Alfa 40000 UNT/ML
Drug: Sodium Chloride 0.9%

First Posted Date: 2020-10-19

Last Posted Date: 2023-10-03

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 2500

Registration Number: NCT04588311

Locations: 🇸🇦
King Abdulaziz Medical City, Riyadh, Saudi Arabia
🇮🇪
Cork University Hospital, Cork, Ireland
🇨🇭
St. Gallen Cantonal Hospital, Saint Gallen, Switzerland

and more 31 locations

Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis

Phase 3

Recruiting

Conditions: Shock, Septic

Interventions: Drug: Vasopressor
Other: Fluids

First Posted Date: 2020-09-30

Last Posted Date: 2023-10-26

Lead Sponsor: Australian and New Zealand Intensive Care Research Centre

Target Recruit Count: 1000

Registration Number: NCT04569942

Locations: 🇦🇺
The Queen Elizabeth Hospital, Adelaide, South Australia, Australia
🇦🇺
St John of God Murdoch Hospital, Murdoch, Western Australia, Australia
🇦🇺
Royal Perth Hospital, Perth, Western Australia, Australia

and more 14 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy